8-K - Guardian Pharmacy Services, Inc. (0001802255) (Filer)

SCHEDULE 13G/A - Guardian Pharmacy Services, Inc. (0001802255) (Subject)

SCHEDULE 13G - Guardian Pharmacy Services, Inc. (0001802255) (Subject)

10-Q - Guardian Pharmacy Services, Inc. (0001802255) (Filer)

8-K - Guardian Pharmacy Services, Inc. (0001802255) (Filer)

424B3 - Guardian Pharmacy Services, Inc. (0001802255) (Filer)

8-K - Guardian Pharmacy Services, Inc. (0001802255) (Filer)

S-3 - Guardian Pharmacy Services, Inc. (0001802255) (Filer)

8-K - Guardian Pharmacy Services, Inc. (0001802255) (Filer)

SCHEDULE 13G/A - Guardian Pharmacy Services, Inc. (0001802255) (Subject)

4 - Guardian Pharmacy Services, Inc. (0001802255) (Issuer)

4 - Guardian Pharmacy Services, Inc. (0001802255) (Issuer)

4 - Guardian Pharmacy Services, Inc. (0001802255) (Issuer)

4 - Guardian Pharmacy Services, Inc. (0001802255) (Issuer)

4 - Guardian Pharmacy Services, Inc. (0001802255) (Issuer)

4 - Guardian Pharmacy Services, Inc. (0001802255) (Issuer)

Oppenheimer initiated coverage of Guardian Pharmacy Services with a rating of Outperform and set a new price target of $30.00

Raymond James initiated coverage of Guardian Pharmacy Services with a rating of Outperform and set a new price target of $21.00

Truist initiated coverage of Guardian Pharmacy Services with a rating of Buy and set a new price target of $22.00

4 - Guardian Pharmacy Services, Inc. (0001802255) (Issuer)

4 - Guardian Pharmacy Services, Inc. (0001802255) (Issuer)

4 - Guardian Pharmacy Services, Inc. (0001802255) (Issuer)

4 - Guardian Pharmacy Services, Inc. (0001802255) (Issuer)

4 - Guardian Pharmacy Services, Inc. (0001802255) (Issuer)

4 - Guardian Pharmacy Services, Inc. (0001802255) (Issuer)

4 - Guardian Pharmacy Services, Inc. (0001802255) (Issuer)

4 - Guardian Pharmacy Services, Inc. (0001802255) (Issuer)

4 - Guardian Pharmacy Services, Inc. (0001802255) (Issuer)

4 - Guardian Pharmacy Services, Inc. (0001802255) (Issuer)

Presents Business Update at J.P. Morgan Healthcare Conference Guardian Pharmacy Services (NYSE:GRDN), one of the nation's leading long-term care ("LTC") pharmacy services companies, is reiterating its previously announced 2025 guidance and providing its preliminary financial outlook for 2026. The Company expects to continue its low double-digit adjusted EBITDA growth trajectory in 2026, supported by the strength of its operating model and increased visibility into the year ahead, including anticipated drug pricing changes. The Company will review these and other business updates during its presentation at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco on Wednesday, J

Guardian Pharmacy Services, Inc. (NYSE:GRDN) today confirmed the company will participate in the 44th Annual J.P. Morgan Healthcare Conference in San Francisco, CA. The company's leadership team will host investor meetings on Wednesday, January 14th, and present at 4:30 p.m. PT the same day. A live audio webcast of the session will be available at https://investors.guardianpharmacy.com. A replay will be accessible shortly after the event and will remain available for 30 days. About Guardian Pharmacy Services Guardian Pharmacy Services is one of the nation's leading long-term care pharmacy services companies. Through its locally‑based business model, Guardian partners with long-term care

Guardian Pharmacy Services, Inc. (NYSE:GRDN), one of the nation's leading long-term care ("LTC") pharmacy services companies, announced today its financial results for the third quarter ended September 30, 2025. The Company also raised its full-year revenue and Adjusted EBITDA guidance. Third Quarter Financial Results Revenue of $377.4 million, up 20% year-over-year. Residents served ended the quarter at approximately 204,000, up 13% year-over-year. Net Income (loss) of $9.6 million, compared to ($105.8) million in the prior-year period. Such year-over-year comparison is not meaningful due to income tax expense1 in the recently completed quarter, and certain one-time share-based

Guardian Pharmacy Services, Inc. (NYSE:GRDN) today announced that it will participate in the Stephens Investment Conference in Nashville, TN, on Wednesday, November 19, 2025. The company will host investor meetings, and Fred Burke, Co-founder and Chief Executive Officer, will take part in a fireside chat at 11:00 a.m. CT (12:00 p.m. ET) the same day. A live audio webcast of the session will be available at https://investors.guardianpharmacy.com. A replay will be accessible shortly after the event and will remain available for 90 days. About Guardian Pharmacy Services Guardian Pharmacy Services is one of the nation's leading long-term care pharmacy services companies. Through its local

Guardian Pharmacy Services, Inc. (NYSE:GRDN) ("Guardian"), one of the nation's leading long-term care (LTC) pharmacy services companies, today announced that it has filed a shelf registration statement on Form S-3 with the U.S. Securities and Exchange Commission (SEC). The registration statement relates to (i) the possible issuance and sale of up to 1,020,000 shares of Class A common stock by Guardian and (ii) the potential resale of up to 4,980,000 outstanding shares of Class A common stock by selling stockholders, in each case from time to time and on a continuous or delayed basis. Guardian recently became eligible to file a Form S-3 registration statement and determined that such filin

Guardian Pharmacy Services, Inc. (NYSE:GRDN) announced today that it will release its third quarter 2025 results on Monday, November 10th, 2025, after market close and host a conference call to review the results at 4:30 pm ET. Conference Call Details The conference call will be available via audio webcast at https://investors.guardianpharmacy.com and can also be accessed by dialing (646) 564-2877 for U.S. participants, or +1 (800) 549-8228 for international participants, and referencing conference ID "11965." A replay will be available shortly after the call's completion and will remain available for approximately 60 days. About Guardian Pharmacy Services Guardian Pharmacy Services

Guardian Pharmacy Services, Inc. (NYSE:GRDN) today announced that it will participate in the Jefferies Healthcare Services Conference in Nashville, TN, on Tuesday, September 30, 2025. The company will host investor meetings, and Fred Burke, Co-founder and Chief Executive Officer, will take part in a fireside chat with Jefferies analyst, Brian Tanquilut, at 3:35 p.m. CT (4:35 p.m. ET) the same day. A live audio webcast of the session will be available at https://investors.guardianpharmacy.com. A replay will be accessible shortly after the event and will remain available for 90 days. About Guardian Pharmacy Services Guardian Pharmacy Services is one of the nation's leading long-term car

Guardian Pharmacy Services, Inc. (NYSE:GRDN), one of the nation's leading long-term care ("LTC") pharmacy services companies, announced today its financial results for the second quarter ended June 30, 2025. Second Quarter Financial Results Revenue of $344.3 million, up 15% year-over-year, driven by low double-digit organic growth and acquisitions completed over the past 12 months. Resident count ended the quarter over 195,000, up 12% year-over-year. Net Income of $8.8 million, compared to $15.8 million in the prior-year period. This is not a meaningful comparison primarily due to income tax1 and share-based compensation expenses2 in the recently completed quarter. Adjusted EB

Guardian Pharmacy Services, Inc. (NYSE:GRDN), one of the nation's leading long-term care (LTC) pharmacy services companies, today announced its acquisition of Managed Healthcare Pharmacy, a leading LTC pharmacy in Oregon with locations in Eugene and Medford. This transaction marks a significant milestone for Guardian, establishing its first physical footprint in the state and expanding its presence in the Pacific Northwest. The newly acquired pharmacy serves residents in assisted living and behavioral health communities, as well as individuals with intellectual and developmental disabilities. Established in 1991, Managed Healthcare Pharmacy is one of Oregon's largest LTC pharmacies, with

Guardian Pharmacy Services, Inc. (NYSE:GRDN) announced today that it will release its second quarter 2025 results on Monday, August 11, 2025, after market close and host a conference call to review the results at 4:30 pm ET. Conference Call Details The conference call will be available via audio webcast at https://investors.guardianpharmacy.com and can also be accessed by dialing (646) 564-2877 for U.S. participants, or +1 (800) 549-8228 for international participants, and referencing conference ID "95006." A replay will be available shortly after the call's completion and will remain available for approximately 60 days. About Guardian Pharmacy Services Guardian Pharmacy Services is

Guardian Pharmacy Services, Inc. ("Guardian") (NYSE:GRDN), one of the nation's largest and most innovative long-term care (LTC) pharmacy services companies is pleased to announce the appointment of Ashley Stockton as Senior Director, Head of Investor Relations. She will be responsible for leading the investor relations strategy and serving as the primary liaison with shareholders, analysts, and the broader investment community. Ashley joins Guardian with nearly thirty years of experience in equity markets. Most recently, she served as Head of Southeast Institutional Equity Sales for J.P. Morgan, where she built and managed strategic partnerships with institutional investors, delivering dif

Guardian Pharmacy Services, (NYSE:GRDN), one of the nation's largest and most innovative long-term care (LTC) pharmacy services companies, today announced that Freedom Pharmacy, an independent LTC pharmacy based in Randolph, New Jersey, is joining the Guardian family. The pharmacy will continue to operate under the name Freedom Pharmacy and serve residents in assisted living and skilled nursing, as well as individuals with intellectual and developmental disabilities throughout North, Northwest and Central New Jersey, with plans to further increase its presence across the Garden State in the future. This strategic partnership expands Guardian's Mid-Atlantic footprint and marks its first vent

Guardian Pharmacy Services, Inc. (NYSE:GRDN), one of the nation's leading long-term care ("LTC") pharmacy services companies, announced today its financial results for the third quarter ended September 30, 2025. The Company also raised its full-year revenue and Adjusted EBITDA guidance. Third Quarter Financial Results Revenue of $377.4 million, up 20% year-over-year. Residents served ended the quarter at approximately 204,000, up 13% year-over-year. Net Income (loss) of $9.6 million, compared to ($105.8) million in the prior-year period. Such year-over-year comparison is not meaningful due to income tax expense1 in the recently completed quarter, and certain one-time share-based

Guardian Pharmacy Services, Inc. (NYSE:GRDN) announced today that it will release its third quarter 2025 results on Monday, November 10th, 2025, after market close and host a conference call to review the results at 4:30 pm ET. Conference Call Details The conference call will be available via audio webcast at https://investors.guardianpharmacy.com and can also be accessed by dialing (646) 564-2877 for U.S. participants, or +1 (800) 549-8228 for international participants, and referencing conference ID "11965." A replay will be available shortly after the call's completion and will remain available for approximately 60 days. About Guardian Pharmacy Services Guardian Pharmacy Services

Guardian Pharmacy Services, Inc. (NYSE:GRDN), one of the nation's leading long-term care ("LTC") pharmacy services companies, announced today its financial results for the second quarter ended June 30, 2025. Second Quarter Financial Results Revenue of $344.3 million, up 15% year-over-year, driven by low double-digit organic growth and acquisitions completed over the past 12 months. Resident count ended the quarter over 195,000, up 12% year-over-year. Net Income of $8.8 million, compared to $15.8 million in the prior-year period. This is not a meaningful comparison primarily due to income tax1 and share-based compensation expenses2 in the recently completed quarter. Adjusted EB

Guardian Pharmacy Services, Inc. (NYSE:GRDN) announced today that it will release its second quarter 2025 results on Monday, August 11, 2025, after market close and host a conference call to review the results at 4:30 pm ET. Conference Call Details The conference call will be available via audio webcast at https://investors.guardianpharmacy.com and can also be accessed by dialing (646) 564-2877 for U.S. participants, or +1 (800) 549-8228 for international participants, and referencing conference ID "95006." A replay will be available shortly after the call's completion and will remain available for approximately 60 days. About Guardian Pharmacy Services Guardian Pharmacy Services is

Guardian Pharmacy Services, Inc. (NYSE:GRDN), one of the nation's largest and most innovative long-term care (LTC) pharmacy services companies, today announced the acquisition of Senior Care Pharmacy in Wichita, Kan. The acquisition expands Guardian's operations into south central and southwest Kansas, strengthening its overall presence across the state and enabling it to bring its high-quality pharmacy services to residents in assisted living, skilled nursing and behavioral health communities, as well as individuals with intellectual and developmental disabilities in these newly served areas. With the addition of the Wichita location, Guardian now operates two pharmacies in Kansas – Kansa

Guardian Pharmacy Services, Inc. (NYSE:GRDN), one of the nation's largest long-term care (LTC) pharmacy services companies, today announced that it will release its first quarter 2025 results on Monday, May 12, 2025, after market close and host a conference call to review the results at 4:30 pm ET. Conference Call Details The conference call will be available via audio webcast at https://investors.guardianpharmacy.com and can also be accessed by dialing (646) 564-2877 for U.S. participants, or +1 (800) 549-8228 for international participants, and referencing conference ID "96083." A replay will be available shortly after the call's completion and remain available for approximately 60 days

Guardian Pharmacy Services, Inc. (NYSE:GRDN), one of the nation's largest long-term care (LTC) pharmacy services companies, today announced that it will release its third quarter 2024 results on Tuesday, November 12, 2024, after market close and host a conference call to review the results at 4:30pm ET. Conference Call Details The conference call will be available via audio webcast at https://investors.guardianpharmacy.com and can also be accessed by dialing (800) 245-3047 for U.S. participants, or (203) 518-9765 for international participants, and referencing conference ID "Guardian." A replay will be available shortly after the call's completion and remain available for approximately 60

SC 13G - Guardian Pharmacy Services, Inc. (0001802255) (Subject)

SC 13G - Guardian Pharmacy Services, Inc. (0001802255) (Subject)

SC 13G - Guardian Pharmacy Services, Inc. (0001802255) (Subject)

SC 13G - Guardian Pharmacy Services, Inc. (0001802255) (Subject)

SC 13G - Guardian Pharmacy Services, Inc. (0001802255) (Subject)

SC 13G - Guardian Pharmacy Services, Inc. (0001802255) (Subject)

SC 13G - Guardian Pharmacy Services, Inc. (0001802255) (Subject)